Burguin, A., Diorio, C., & Durocher, F. (2021). Breast cancer treatments: updates and new challenges. Journal of Personalized Medicine, 11(8), 808.
Article PubMed PubMed Central Google Scholar
Xia, L., et al. (2023). The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer. Biochemia Medica, 33(3), 266–278.
Giaquinto, A. N., et al. (2022). Breast cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(6), 524–541.
Arı, A., et al. (2023). Metastatic breast cancer in the uterine cervix. British Journal of Hospital Medicine, 84(11), 1–1.
Trayes, K. P., & Cokenakes, S. E. (2021). Breast cancer treatment. American Family Physician, 104(2), 171–178.
Orrantia-Borunda, E., et al. (2022) Subtypes of breast cancer. Breast Cancer.
Cohen, P. A., et al. (2019). Cervical cancer. The Lancet, 393(10167), 169–182.
Waggoner, S. E. (2003). Cervical cancer. The Lancet, 361(9376), 2217–2225.
Zur Hausen, H. (2009). Papillomaviruses in the causation of human cancers—a brief historical account. Virology, 384(2), 260–265.
Article PubMed CAS Google Scholar
Burd, E.M., & Dean, C.L. (2016). Human papillomavirus. Diagnostic Microbiology of the Immunocompromised Host, 2016, 177–195.
Franceschi, S., et al. (2003). Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case‐control study. International Journal of Cancer, 107(1), 127–133.
Article PubMed CAS Google Scholar
Bujan Rivera, J., & Klug, S. J. (2018). Cervical cancer screening in Germany. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz, 61, 1528–1535.
Smolarz, B., et al. (2022). miRNAs in cancer (review of literature). International Journal of Molecular Sciences, 23(5), 2805.
Article PubMed PubMed Central CAS Google Scholar
Kanwal, N., et al. (2023). Comprehensive analysis of microRNA (miRNA) in cancer cells. Cellular Molecular and Biomedical Reports, 3(2), 89–97.
Shi, Y., et al. (2021). MiRNAs and cancer: key link in diagnosis and therapy. Genes, 12(8), 1289.
Article PubMed PubMed Central CAS Google Scholar
Mohammadi, M., et al. (2024). Correlation of PTEN signaling pathway and miRNA in breast cancer. Molecular Biology Reports, 51(1), 221.
Article PubMed CAS Google Scholar
Chen, C.-Z. (2005), MicroRNAs as oncogenes and tumor suppressors.
Chen, Y., et al. (2014). Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy. Apoptosis, 19, 1177–1189.
Article PubMed CAS Google Scholar
Wang, H. (2020). MicroRNAs and apoptosis in colorectal cancer. International Journal of Molecular Sciences, 21(15), 5353.
Article PubMed PubMed Central CAS Google Scholar
Hongmei, Z. (2012), Extrinsic and intrinsic apoptosis signal pathway review, in Apoptosis and medicine, InTechOpen.
Jin, Z., & El-Deiry, W. S. (2005). Overview of cell death signaling pathways. Cancer Biology & Therapy, 4(2), 147–171.
Harris, B. R., et al. (2018). Induction of the p53 tumor suppressor in cancer cells through inhibition of cap-dependent translation. Molecular and Cellular Biology, 38(10), e00367–17.
Article PubMed PubMed Central CAS Google Scholar
Beilankouhi, E.A.V., et al. (2023). Role of the ER-induced UPR pathway, apoptosis, and autophagy in colorectal cancer. Pathology-Research and Practice, 154706.
Lynam‐Lennon, N., Maher, S. G., & Reynolds, J. V. (2009). The roles of microRNA in cancer and apoptosis. Biological Reviews, 84(1), 55–71.
Qian, S., et al. (2022). The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Frontiers in Oncology, 12, 985363.
Article PubMed PubMed Central CAS Google Scholar
Singh, R., Letai, A., & Sarosiek, K. (2019). Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nature Reviews Molecular cell biology, 20(3), 175–193.
Article PubMed PubMed Central CAS Google Scholar
Campbell, K. J., & Tait, S. W. (2018). Targeting BCL-2 regulated apoptosis in cancer. Open Biology, 8(5), 180002.
Article PubMed PubMed Central Google Scholar
Kashyap, D., Garg, V. K., & Goel, N. (2021). Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis. Advances in Protein Chemistry and Structural Biology, 125, 73–120.
Article PubMed CAS Google Scholar
Shahar, N., & Larisch, S. (2020). Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance. Drug Resistance Updates, 52, 100712.
Cossu, F., et al. (2019). Targeting the BIR domains of inhibitor of apoptosis (IAP) proteins in cancer treatment. Computational and Structural Biotechnology Journal, 17, 142–150.
Article PubMed PubMed Central CAS Google Scholar
Bao, M. H., et al. (2016). Effects of miR‑590 on oxLDL‑induced endothelial cell apoptosis: Roles of p53 and NF‑κB. Molecular Medicine Reports, 13(1), 867–873.
Article PubMed CAS Google Scholar
Loh, H.-Y., et al. (2019). The regulatory role of microRNAs in breast cancer. International Journal of Molecular Sciences, 20(19), 4940.
Article PubMed PubMed Central CAS Google Scholar
Yang, Z., & Liu Z. (2020). The emerging role of microRNAs in breast cancer. Journal of Oncology
Mamalo, A.S., et al. (2023). Potential roles of the exosome/microRNA axis in Breast cancer. Pathology-Research and Practice. 154845.
Saikia, M., Paul, S., & Chakraborty, S. (2020). Role of microRNA in forming breast carcinoma. Life Sciences, 259, 118256.
Article PubMed CAS Google Scholar
Zhang, B., et al. (2007). microRNAs as oncogenes and tumor suppressors. Developmental biology, 302(1), 1–12.
Article PubMed CAS Google Scholar
Zhang, L.-L., et al. (2014). MiR-886-5p inhibition inhibits growth and induces apoptosis of MCF7 cells. Asian Pacific Journal of Cancer Prevention, 15(4), 1511–1515.
Najjary, S., et al. (2020). Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer. Gene, 738, 144453.
Article PubMed CAS Google Scholar
Wang, X., et al. (2017). Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell. Oncology Letters, 13(6), 4825–4831.
Article PubMed PubMed Central CAS Google Scholar
Breunig, C., et al. (2017). MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells. Cell Death & Disease, 8(8), e2973–e2973.
Comments (0)